FTXH ETF
First Trust Nasdaq Pharmaceuticals ETF
FTXH ETF Overview
FTXH ETF (First Trust Nasdaq Pharmaceuticals ETF) is managed by First Trust Portfolios (US) with $1.06B in net assets. FTXH expense ratio is 0.60%, holding 100 positions across sectors including Health Care. Inception date: 2016-09-20.
FTXH performance shows a YTD return of 17.72%. The 1-year return is 52.38% and the 5-year return is 9.54%. FTXH dividend yield stands at 1.03%, paid quarterly.
FTXH top holdings include Merck & Company Inc (7.6%), Abbvie Inc. (7.0%), Eli Lilly & Co. (7.0%), Bristol-Myers Squibb Co. (6.8%), Johnson & Johnson - Common (6.8%). Go to all FTXH holdings, FTXH sectors, or FTXH dividends.
FTXH can be compared against other funds. Use FTXH overlap to find shared positions, or FTXH vs another fund for a side-by-side view. FTXH alternatives are available via the screener, along with tax-loss harvesting opportunities.